Internal Medicine, Infectious Disease · Henderson, NV
NPI
1861728198
Since 2009
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
825 N Gibson Rd Ste 311
Henderson, NV, 89011
Phone (702) 776-8300
Groups this clinician bills Medicare through
Medicare paid, 2024
$151K
2,279 services
Medicare patients, 2024
377
Average age 74
Drug cost, 2024
$681K
734 prescriptions
Company payments, 2025
$112
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mir A Mohammad was code 99232 (hospital e&m - subsequent), 1,809 times for 328 patients. In total Mir A Mohammad billed 2,279 services in 8 codes, and Medicare paid $151K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,809 | 328 | $60.42 | $109K |
| 99222 Hospital E&M - Initial | Facility | 227 | 201 | $99.40 | $23K |
| 99213 Office E&M - Established | Office | 172 | 56 | $62.31 | $11K |
| 99223 Hospital E&M - Initial | Facility | 57 | 51 | $133.08 | $7,586 |
By year: 2022 $175K for 2,701 services; 2023 $154K for 2,271 services; 2024 $151K for 2,279 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mir A Mohammad prescribed most often to Medicare patients was Daptomycin, with 143 prescriptions and refills. In total Mir A Mohammad wrote 734 Medicare prescriptions that cost $681K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Daptomycin Generic | 143 | 143 | 38 | $127K |
| Ertapenem Ertapenem Sodium | 90 | 90 | 29 | $36K |
| Sodium Chloride 0.9 % Sodium Chloride | 58 | 58 | Under 11 | $675 |
| Meropenem Generic | 57 | 57 | 19 | $7,370 |
| Ceftriaxone Ceftriaxone Sodium | 30 | 30 | 13 | $2,595 |
| Cefepime Hcl Generic | 27 | 27 | 12 | $3,298 |
| Doxycycline Hyclate Generic | 24 | 24 | Under 11 | $342 |
| Fluconazole Generic | 24 | 28 | Under 11 | $1,092 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 22 | 22 | Under 11 | $85K |
| Fetroja Cefiderocol Sulfate Tosylate | 22 | 22 | Under 11 | $88K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 20 | 20 | Under 11 | $80K |
| Vancomycin Hcl Generic | 16 | 16 | Under 11 | $1,211 |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 14 | 14 | Under 11 | $2,790 |
| Oxacillin Sodium Generic | 13 | 13 | Under 11 | $10K |
| Isentress Raltegravir Potassium | 12 | 12 | Under 11 | $24K |
Brand drugs: 195 claims; generic drugs: 539 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mir A Mohammad $112 ($112 in general payments such as food, travel and fees) from 2 companies. The largest payer was Merck Sharp & Dohme LLC with $94.65.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.